Al Sbihi, Ali and Manasrah, Nouraldeen and Sano, Dahlia (2022) Can Lenalidomide Protect against Severe COVID-19 Symptoms in Multiple Myeloma Patients? A Case Series and Review of the Literature. European Journal of Case Reports in Internal Medicine, 9 (3). pp. 1-3. ISSN 2284-2594
|
Text
3216-Article Text-27843-1-10-20220308.pdf - Published Version Download (192kB) | Preview |
Official URL: https://www.ejcrim.com/index.php/EJCRIM/article/vi...
Abstract
We present a case series of three multiple myeloma (MM) patients on lenalidomide for maintenance therapy who were at high risk of coronavirus disease 2019 (COVID-19) complications and mortality. However, our patients had minor symptoms after testing positive for COVID-19 although they were unvaccinated. We think that lenalidomide might have a protective effect against severe COVID-19 symptoms.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | COVID-19, multiple myeloma, lenalidomide |
| Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 14 Apr 2022 13:36 |
| Last Modified: | 14 Apr 2022 13:36 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21826 |
Actions (login required)
 |
View Item |
